<code id='09911D0271'></code><style id='09911D0271'></style>
    • <acronym id='09911D0271'></acronym>
      <center id='09911D0271'><center id='09911D0271'><tfoot id='09911D0271'></tfoot></center><abbr id='09911D0271'><dir id='09911D0271'><tfoot id='09911D0271'></tfoot><noframes id='09911D0271'>

    • <optgroup id='09911D0271'><strike id='09911D0271'><sup id='09911D0271'></sup></strike><code id='09911D0271'></code></optgroup>
        1. <b id='09911D0271'><label id='09911D0271'><select id='09911D0271'><dt id='09911D0271'><span id='09911D0271'></span></dt></select></label></b><u id='09911D0271'></u>
          <i id='09911D0271'><strike id='09911D0271'><tt id='09911D0271'><pre id='09911D0271'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:722
          Attendees at the MedTech Conference in Anaheim, California. -- health tech coverage from STAT
          Attendees at the AdvaMed Conference in Anaheim, Calif., on Tuesday. Eric Thayer for STAT

          ANAHEIM, Calif. — Thousands of workers in the medical device industry gathered here this week for the MedTech Conference, creating an eerie dissonance with Disneyland tourists clad in Mickey Mouse ears and fanny packs.

          Device makers and analysts at the conference, hosted by device lobby AdvaMed, came together to discuss medical technology’s innovation problem, the industry’s deepening relationship with the Food and Drug Administration, and the growing opportunities in digital health.

          advertisement

          After a couple of years of tremendous gains generated by the pandemic’s demand for medical equipment, the medical device industry has hit a slump. In its annual medtech report, EY reported a 30% decline in all industry financing, which includes a drop in initial public offerings, special-purpose acquisition company deals, and venture capital funding.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Medtronic CEO on promising devices for diabetes, hypertension
          Medtronic CEO on promising devices for diabetes, hypertension

          GeoffMartha,CEOofMedtronicCourtesyMedtronicAsoneofthelargestandoldestmedicaldevicecompaniesintheworl

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Second xenotransplant done with gene

          TheUniversityofMarylandteampreparesthepigheartfortransplant.CourtesyUniversityofMarylandSchoolofMedi